Long-term use of penicillin for the treatment of chronic plaque psoriasis

European Journal of Dermatology

Volumn 15, Issue 5, 2005, Pages 359-362

  Saxena, V N ^a   Dogra, J ^b  

^a SMS MEDICAL COLLEGE   (India)

^b CGHS   (India)

Author keywords

Benzathine penicillin; Chronic plaque psoriasis

Indexed keywords

BENZATHINE PENICILLIN; PENICILLIN G;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN TISSUE; LONG TERM CARE; MALE; PSORIASIS VULGARIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTISTREPTOLYSIN; CHILD; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PENICILLIN G, BENZATHINE; PSORIASIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 25144439937     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wrone-Smith T, Nickoloff BJ. Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996; 98: 1878-87.
2. Gilhar A, David M, Ullmann Y, et al. T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice. J invest Dematol 1997; 109: 283-8.
3. Wong RL, Winslow CM, Cooper KD. The mechanism of action of cyclosporin A in the treatment of psoriasis. Immunol Today 1993; 14: 69-74.
4. Baker BS, Swain AF, Fryl, et al. Epidermal T lymphocytes and HLA-DR expression in Psoriasis. Br J Dermatol 1984; 110: 555-64.
5. Baker BS, Bokth S, Powles A, et al. Group A streptococcal antigen-specific T.lymphocytes in guttate psoriatic lesions. Br J Dermatol 1993; 128: 493-9.
6. Whyte HJ, Baugham RD. Acute guttate psoriasis and streptococcal infection. Arch Dermatol 1964; 89: 350-6.
7. Tervaert WC, Esseveld H. A study of the incidence of hemolytic streptococci in the throat inpatients with psoriasis vulgaris, with reference to their role in the pathogenesis of this disease. Dermatologica 1970; 140: 282-90.
8. Telfer NR, Chalmers RJ, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 1992; 128: 39-42.
9. Honig PJ. Guttate psoriasis associated with perianal streptococcal disease. J Pediatr 1988; 113(6): 1037-9.
10. Williams RC, Mckenzie AW, Roger JH, et al. HLA antigen in patients with guttate psoriasis. Br J Dermatol 1976; 95: 163-7.
11. Rosenberg EW, Noah PW. The Koebner phenomenon and the microbial basis of psoriasis. J Am Acad Dermatol 1988; 18: 151-2.
12. Valdimarsson H, Baker BS, Jonsdottir I, et al. Psoriasis: a disease of abnormal kertinocyte proliferation induced by T Lymphocytes. Immunol Today 1986; 7: 256-9.
13. Gupta AK, Ellis CN, Nickoloff BJ, et al. Oral cyclosporin in the treatment of inflammatory and non-inflammatory dermatosis. A clinical and pathologic analysis. Arch Dematol 1990; 126: 339-50.
14. Sigmundsdottir H, Sigurgirsson B, Troye-Blomberg M, et al. Circulating T cells of patients with active psoriasis respond to streptococcal M- peptides sharing sequences with human epidermal keratins. Scand J Immunol 1997; 45: 688-97.
15. Valdimarsson H, Baker BS, Jonsdottir I, et al. Psoriasis: a T cell mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995; 16: 145-9.
16. Leung DYM, Travers JB, Giorno R, et al. Evidence for a streptococcal superantigen driven process in acute guttate psoriasis. J Clin Invest 1995; 96(5): 2106-12.
17. Leung DYM, Hauk P, Strickland I, et al. The role of superantigens in human diseases: Therapentic implications for the treatment of skin diseases. Br J Dermatol 1998; 139: 17-29.
18. Cohen-Terveart WC, Esseveld H. A study of the incidence of hemolytic streptococci in the throat of patients with psoriasis vulgaris, with reference to their role in the pathogenesis of this disease. Dermatologica 1970; 140: 282-90.
19. Rosenberg EW, Noah PW, Zanoilli MD, Skinner Jr. RB, Bond MJ, Crutcher N. Use of rifampicin with penicillin and erythromycin in the treatment of psoriasis. J Am Acad Dermatol 1986; 14: 761-4.
20. Ohshima A, Takigawa M. To kura Y. CD8+ cell changes in psoriasis associate with roxithromycin-induced clinical improvement. Eur J Dermatol 2001; 11: 410-5.
21. Mc Fadden J, Gill GS, Powles AV, et al. Components of streptococcal M surface antigen and human keratin are homologous. J Invest Dermatol 1989; 93: 303; (Abstract).
22. Romagnani S. Lymphokine production by human T Cells in disease stages. Annu Rev Immunol 1994; 12: 227-57.
23. th edn. New York Mc Graw-Hill, 2001: 1340-3.
24. Bertrams J, Lattke CL, Kuwert E. Correlation of antistreptolycin O titre to HLA-13 in psoriasis. N Engl J Med 1974; 291: 631.
25. Baker BS, Powles AV, Malkani AK, et al. Altered cell-mediated immunity to group A haemolytic streptococcal antigens in chronic plaque psoriasis. BJ Dermatol 1991; 125: 38-42.
26. Blok S, Vissers WHPM, van Duijnhoven M, van de Kerkhof PCM. Aggravation of psoriasis by infection: a constitutional triat or a variable expression? Eur J Dermatol 2004; 14: 259-61.
27. Noah PW, Bale G, Eilert V, et al. Streptococcal products in the epidermis of patients with streptococcal associated psoriasis: detection by immunofluroscence with monoclonal and polyclonal anti streptococcal antibodies. J Invest Dermatol 1986: 497.
28. Vincent F, Ross JB, Dalton M, et al. A therapeutic trial of the use of penicillin V or erythromycin with or without rifampin in the treatment of psoriasis. J Am Acad Dermatol 1992; 26: 458-61.